Lead attorney for Apple assembly firm Foxconn released a statement saying that neither Foxconn nor Apple would seek a settlement in court with Qualcomm over the companies’ ongoing legal tug-of-war.
The conflict is but one aspect of the global legal battle between regulators, Apple, and Qualcomm—which supplies modem chips that help phones connect to wireless data networks.
Last week, Qualcomm secured a preliminary victory in a patent lawsuit in China that would have banned sales of some Apple iPhones there. Apple later stated it believed it was already in compliance, but would change its software “to address any possible concern” about its compliance.
The group of contract manufacturers—which includes Foxconn parent Hon Hai Precision Industry, Pegatron Corp, Wistron Corp, and Compal Electronics—became embroiled in the dispute between Apple and Qualcomm last year.
In the supply chain for electronics, contract manufacturers buy Qualcomm chips and pay royalties when they build phones, and are in turn reimbursed by companies like Apple. Qualcomm sued the group last year, alleging they had stopped paying royalties related to Apple products, and Apple joined the defense.
In response to Qualcomm’s lawsuit, the group of manufacturers filed their own lawsuit against Qualcomm. The group is seeking US$9 billion in damages for Qualcomm’s practice of charging money for chips but then also asking for a cut of the adjusted selling price of a mobile phone as a patent royalty payment. The manufacturers’ group claims this constitutes an anticompetitive business practice.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan